IP Library Granted Patent US 10,752,925
Granted Patent B2
US 10,752,925 · App. 16/015,101 · Granted Aug 25, 2020

Microbial production of succinate derived products

Inventors: Ka-Yiu San (Houston, TX); George N. Bennett (Houston, TX); Irene Martinez (Houston, TX)
Assignee: William Marsh Rice University
C12P7/46C12N9/88C12Y402/01002C12Y604/01001
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,752,925
App. No.
16/015,101
Granted
Aug 25, 2020
Kind
B2
Abstract

Microbes and methods used to convert renewable carbon sources such as glucose, sucrose, biomass hydrolysate, methanol or formate, to succinate-derived products, such as fumarate or malate, which are desirable products having many uses.

Claims (16)

1. An engineered bacteria having

a deletion of one or more fumarase enzymes and able to convert succinate to fumarate; and

an overexpressed succinyl co-A ligase and succinical-semialdehyde dehydrogenase and succinic semialdehyde reductase (EC 1.1.1.B47) and able to convert succinate to 4-hydroxybutyrate.

2. The bacteria of claim 1 , further comprising a) overexpressed pyruvate carboxylase and b) deletions of i) ldhA, ii) adhE, iii) iclR and iv) ackA or pta or ackA-pta.

3. A method of making a succinate-derived product, comprising:

a. growing an engineered bacteria of claim 1 in a culture medium;

b. allowing said bacteria to anaerobically make succinate;

c. allowing said bacteria to convert succinate to a succinate-derived product under aerobic conditions; and

d. isolating said succinate-derived product from said bacteria, said medium, or both.

4. The method of claim 3 , wherein said bacteria has overexpressed pyruvate carboxylase.

5. The method of claim 4 , wherein said bacteria has a deletion of i) ldhA, ii) adhE, iii) iclR and iv) ackA or pta or ackA-pta.

6. The method of claim 3 , wherein said bacteria has a deletion of i) ldhA, ii) adhE, iii) iclR and iv) ackA or pta or ackA-pta.

7. The method of claim 3 , wherein said bacteria comprises:

a. overexpressed pyruvate carboxylase;

b. a deletion of i) ldhA, ii) adhE, iii) iclR and iv) ackA or pta or ackA-pta; and

c. said bacteria produces at least 1.2 moles of fumarate per mole of glucose.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 3, 2018
From: SAN, KA-YIU; BENNETT, GEORGE N; MARTINEZ, IRENE
To: WILLIAM MARSH RICE UNIVERSITY
Reel/Frame 046553/0824 →
CONFIRMATORY LICENSE Recorded Jul 16, 2018
From: RICE UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 046555/0553 →
Continuity (2)
Provisional Application 62523595 · Jun 22, 2017
Related Publication 20180371508A1 · Dec 27, 2018